Last reviewed · How we verify
NCT04215094
Early Diagnosis of Intracranial Infection After Craniotomy
trial testing postoperative fever, serum procalcitonin, C-reactive protein and white blood cell coun in Intracranial; Infection, Psychosis, Acute or Subacute in 500 participants. Status unknown.
12 July 2021
Quick facts
| Lead sponsor | Pan Jun |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 12 January 2020 |
| Primary completion | 12 July 2021 |
| Estimated completion | 1 August 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- postoperative fever, serum procalcitonin, C-reactive protein and white blood cell coun
Conditions studied
- Intracranial; Infection, Psychosis, Acute or Subacute — all drugs for Intracranial; Infection, Psychosis, Acute or Subacute →
Sponsor
Pan Jun
Who can join
Adults 18 to 68, any sex, with Intracranial; Infection, Psychosis, Acute or Subacute. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Intracranial infection are serious complications postoperatively in neurosurgical patients. Early identification of these complications is essential to minimize the mortality and moribidy. The aim of this study is observe the postoperative dynamic changes of body temperature (BT), procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) count, and evaluate whether the use of two or more of these markers may improve the diagnostic accuracy of intracranial infection.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04215094
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04215094 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pan Jun
- Last refreshed: 23 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04215094.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing